Tafluprost

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 284 publications

Tafluprost/timolol fixed-dose combination versus tafluprost monotherapy for open-angle glaucoma and ocular hypertension: a multicenter, randomized, double-blind, parallel-group trial

Tafluprost/timolol fixed-dose combination versus tafluprost monotherapy for open-angle glaucoma and ocular hypertension: a multicenter, randomized, double-blind, parallel-group trial

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: September 07, 2026

Omidenepag isopropyl (Omlonti) for glaucoma.

Omidenepag isopropyl (Omlonti) for glaucoma.

Journal: The Medical letter on drugs and therapeutics

Published: July 14, 2026

Efficacy and safety of tafluprost-timolol fixed-dose combination in open-angle glaucoma and ocular hypertension.

Efficacy and safety of tafluprost-timolol fixed-dose combination in open-angle glaucoma and ocular hypertension.

Journal: European journal of ophthalmology

Published: January 28, 2026

A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension.

A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: January 12, 2026

Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine®) with Latanoprost Eye Drops (Xalatan®) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension.

Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine®) with Latanoprost Eye Drops (Xalatan®) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension.

Journal: Journal of clinical medicine

Published: November 11, 2025

The Effect of Preoperative Use of High- vs. Low-PAP-Inducing-Potential FP Agonists on the Surgical Outcomes of Trabeculectomy and AGV Implantation.

The Effect of Preoperative Use of High- vs. Low-PAP-Inducing-Potential FP Agonists on the Surgical Outcomes of Trabeculectomy and AGV Implantation.

Journal: Journal of clinical medicine

Published: August 22, 2025

Regional variation and trends in prostaglandin analogue prescribing for glaucoma in England 2019-2024.

Regional variation and trends in prostaglandin analogue prescribing for glaucoma in England 2019-2024.

Journal: Eye (London, England)

Published: August 18, 2025

Efficacy and safety of netarsudil compared with prostaglandin-based therapies: a Bayesian network meta-analysis.

Efficacy and safety of netarsudil compared with prostaglandin-based therapies: a Bayesian network meta-analysis.

Journal: International ophthalmology

Published: August 07, 2025

Effectiveness and Safety of Switching to Fixed-Dose, Preservative-Free Tafluprost/Timolol in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: A Real-World Study in Taiwan.

Effectiveness and Safety of Switching to Fixed-Dose, Preservative-Free Tafluprost/Timolol in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: A Real-World Study in Taiwan.

Journal: Cureus

Published: June 12, 2025

Efficacy and safety of prostaglandin drugs for elevated intraocular pressure: a Bayesian network meta-analysis.

Efficacy and safety of prostaglandin drugs for elevated intraocular pressure: a Bayesian network meta-analysis.

Journal: Frontiers in medicine

Published: June 07, 2025

Drugs for open-angle glaucoma.

Drugs for open-angle glaucoma.

Journal: The Medical letter on drugs and therapeutics

Published: April 22, 2025

Pseudoexfoliation Glaucoma Selective Laser for Trabeculoplasty Treatment in Vietnam.

Pseudoexfoliation Glaucoma Selective Laser for Trabeculoplasty Treatment in Vietnam.

Journal: Endocrine, metabolic & immune disorders drug targets

Published: March 12, 2025

Showing 1-12 of 284

Last Updated: 09/26/2026